As ACOX2 was suggested to be elevated at the mRNA level in over 10% of NSCLC [12], we undertook an analysis of this gene in NSCLC to determine if it had any potential utility as a biomarker in lung cancer at both mRNA and protein level. The gene discussed is ACOX2; the disease is lung carcinoma.